FBC
GERN icon

Fairfield, Bush & Co’s Geron GERN Stock Holding History

Fairfield, Bush & Co’s Portfolio GERN Stock Details GERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed – – 237
2022
Q2 		$0 Buy
+100
New +$141 ﹤0.01% 473

Other funds holding GERN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fairfield, Bush & Co's GERN Position: Q3 2022 in Review

Fairfield, Bush & Co sold out of Geron (GERN) in Q3 2022, closing a stake of 100 shares.

Fairfield, Bush & Co first reported a position in GERN in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 179 funds tracked by Wall St. Rank hold GERN as of Q3 2022.

  • Fairfield, Bush & Co reported no remaining Geron position as of Q3 2022 after selling out during the quarter.
  • Fairfield, Bush & Co sold 100 Geron shares in Q3 2022.
  • Fairfield, Bush & Co first reported a position in Geron in Q2 2022 and held it in 1 quarter.
  • Fairfield, Bush & Co's Geron position peaked at $0 in Q2 2022.
  • 179 funds tracked by Wall St. Rank held Geron as of Q3 2022.

Based on Fairfield, Bush & Co's 13F filing for Q3 2022, filed 7 Nov 2022.